The Pet Diabetes Care Devices by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Pet Diabetes Care Devices Market:
https://www.thebusinessresearchcompany.com/report/pet-diabetes-care-devices-global-market-report
According to The Business Research Company’s Pet Diabetes Care Devices, The pet diabetes care devices market size has grown strongly in recent years. It will grow from $2.4 billion in 2023 to $2.58 billion in 2024 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to introduction of glucose monitoring devices, increase in pet diabetes cases, improvement in treatment outcomes, rise in pet healthcare expenditure, education and veterinary support.
The pet diabetes care devices market size is expected to see strong growth in the next few years. It will grow to $3.6 billion in 2028 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to rise in pet health awareness, adoption of connected devices, personalized treatment solutions, telehealth expansion, research and development investments. Major trends in the forecast period include collaboration and partnerships, innovations in insulin delivery, education and awareness, telemedicine and remote veterinary care, personalized and targeted treatment.
Increasing pet health expenditure is expected to propel the growth of the pet diabetes care device market going forward. Pet health expenditure refers to the amount of money spent by owners on their pets’ health issues. The expenditure for pet healthcare includes the veterinary care, equipment, and pet healthcare devices required. For instance, in October 2022, according to the data released by the American Veterinary Medical Association, a US-based non-profit organization, between 2020 and 2022, Consumer spending on dogs and cats has increased across the board. Yearly veterinarian visits expenditures for households with one dog grew from $224 in 2020 to $362 in 2022. In 2020, the average annual expenditure on veterinarian visits for homes with cats was $189, rising to $321 in 2022. Therefore, the increasing pet health expenditure is driving the growth of the pet diabetes care device market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=9374&type=smp
The pet diabetes care devices market covered in this report is segmented –
1) By Animal Type: Dogs, Cats, Horses
2) By Device: Glucose Monitoring Devices, Insulin Delivery Devices
3) By End Users: Homecare, Veterinary Hospitals, Others End Users
Top Major Players:
- Allison Medical Inc.
- Zoetis Inc.
- Becton Dickinson and Company
- Boehringer Ingelheim Vetmedica Inc.
- Henry Schein Animal Health
North America was the largest region in the pet diabetes care devices market in 2023.
Technological advancements are a key trend in the pet diabetes care device market. Major companies operating in the pet diabetes care device market are developing innovative technologies to strengthen their position in the market. For instance, in February 2023, Zoetis Inc., a US-based veterinary pharmaceutical company, launched the AlphaTrak 3 blood glucose monitoring system intended for cats and dogs in the United States. AlphaTrak 3 encompasses a new mobile app that allows owners of animals and veterinary medical professionals to gather, save, and share data. The AlphaTrak 3 blood glucose monitoring system enables effortless data exchange and communication via the smartphone app, making it quicker to share a pet’s glucose levels and other essential details with the veterinary practice in real time and providing veterinarians and pet owners with increased confidence in diabetic pet care. The AlphaTrak 3 blood glucose monitoring device gives accurate information in as little as five seconds, which is quicker than the existing AlphaTrak 2 blood glucose monitoring system. AlphaTrak 3 uses only 0.3 microliters of blood and delivers a blood sugar dynamic that varies from 20 to 750 milligrams per deciliter. The new AlphaTrak 3 mobile app captures more data from pet owners than prior systems, including their pet’s feeding, drinking, activity, and insulin administration timing.
The pet diabetes care devices market report table of contents includes:
1. Executive Summary
2. Pet Diabetes Care Devices Market Characteristics
3. Global Pet Diabetes Care Devices Market Trends And Strategies
4. Pet Diabetes Care Devices Market – Macro Economic Scenario
5. Global Pet Diabetes Care Devices Market Size and Growth
…….
26. Global Pet Diabetes Care Devices Market Competitive Benchmarking
27. Global Pet Diabetes Care Devices Market Competitive Dashboard
28. Key Mergers and Acquisitions Pet Diabetes Care Devices Market
29. Pet Diabetes Care Devices Market Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
